X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2882) 2882
Book Review (686) 686
Publication (173) 173
Conference Proceeding (18) 18
Book Chapter (15) 15
Web Resource (2) 2
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2599) 2599
humans (1878) 1878
animals (1426) 1426
dipeptidyl-peptidase iv inhibitors - pharmacology (1012) 1012
male (986) 986
diabetes mellitus, type 2 - drug therapy (941) 941
pharmacology & pharmacy (938) 938
dipeptidyl peptidase 4 - metabolism (761) 761
dipeptidyl-peptidase iv inhibitors - therapeutic use (718) 718
glucagon-like peptide-1 (704) 704
type 2 diabetes (637) 637
rats (610) 610
female (556) 556
diabetes (553) 553
hypoglycemic agents - therapeutic use (534) 534
mice (534) 534
hypoglycemic agents - pharmacology (501) 501
endocrinology & metabolism (436) 436
sitagliptin (413) 413
adamantane - analogs & derivatives (346) 346
chemistry, medicinal (344) 344
biochemistry & molecular biology (339) 339
middle aged (338) 338
glucose (334) 334
analysis (293) 293
adult (285) 285
dipeptidyl peptidase-iv (281) 281
double-blind (277) 277
dipeptidyl-peptidase-iv (275) 275
dipeptidyl peptidase iv (269) 269
insulin (269) 269
sitagliptin phosphate (267) 267
dipeptidyl peptidase-4 inhibitor (266) 266
blood glucose - metabolism (262) 262
dipeptidyl-peptidase iv inhibitors - adverse effects (262) 262
dipeptidyl-peptidase iv inhibitors - administration & dosage (251) 251
type-2 diabetes-mellitus (248) 248
peptides (247) 247
hypoglycemic agents (246) 246
blood glucose - drug effects (237) 237
glycemic control (237) 237
vildagliptin (237) 237
diabetes mellitus, type 2 - blood (231) 231
glp-1 (224) 224
aged (223) 223
pyrrolidines - pharmacology (223) 223
structure-activity relationship (221) 221
diabetes mellitus (220) 220
internal medicine (219) 219
metformin (218) 218
research (217) 217
treatment outcome (214) 214
dipeptidyl-peptidase iv inhibitors - pharmacokinetics (210) 210
dose-response relationship, drug (207) 207
dipeptidyl-peptidase iv inhibitors (206) 206
hypoglycemic agents - adverse effects (204) 204
adamantane - pharmacology (199) 199
protease inhibitors - pharmacology (199) 199
dipeptidyl-peptidase iv inhibitors - chemistry (198) 198
mice, inbred c57bl (198) 198
drug therapy, combination (197) 197
diabetes mellitus, type 2 - metabolism (196) 196
expression (194) 194
care and treatment (191) 191
glucagon (187) 187
triazoles - pharmacology (187) 187
rats, wistar (185) 185
pharmacokinetics (183) 183
beta-cell function (182) 182
hypoglycemic agents - administration & dosage (182) 182
peptidase (181) 181
linagliptin (179) 179
dpp-4 inhibitor (177) 177
type 2 diabetes mellitus (177) 177
inhibitors (176) 176
pyrazines - pharmacology (175) 175
medicine, research & experimental (172) 172
nitriles - pharmacology (172) 172
cd26 (170) 170
enzymes (170) 170
dipeptidyl peptidase 4 (166) 166
glucagon-like peptide 1 - metabolism (164) 164
medicine & public health (164) 164
drug therapy (163) 163
administration, oral (159) 159
dextrose (159) 159
dipeptidyl peptidase-4 inhibitors (158) 158
abridged index medicus (157) 157
physiological aspects (156) 156
safety (156) 156
insulin - metabolism (152) 152
dpp-iv (151) 151
dipeptidyl peptidase 4 - chemistry (150) 150
enzyme inhibitors - pharmacology (150) 150
inflammation (147) 147
cell biology (146) 146
health aspects (146) 146
adamantane - therapeutic use (145) 145
disease models, animal (144) 144
chemistry, organic (143) 143
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2829) 2829
Japanese (15) 15
German (12) 12
French (11) 11
Spanish (10) 10
Chinese (7) 7
Hungarian (6) 6
Russian (6) 6
Danish (2) 2
Korean (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Medicinal Chemistry, ISSN 0022-2623, 04/2014, Volume 57, Issue 8, pp. 3205 - 3212
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 09/2007, Volume 9, Issue 5, pp. 733 - 745
Journal Article
Journal of Pharmacology and Experimental Therapeutics, ISSN 0022-3565, 02/2012, Volume 340, Issue 2, pp. 248 - 255
Dipeptidyl peptidase (DPP) IV inhibitors are probably beneficial for preventing diabetic complication and modulating glucagon-like peptide-1 receptor (GLP-1R)... 
FIBROSIS | GROWTH-FACTOR-BETA | TGF-BETA | GLP-1 | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BETA-CELL APOPTOSIS | RECEPTOR EXPRESSION | IMPROVES | PHARMACOLOGY & PHARMACY | NEPHROPATHY | Diabetes Mellitus, Experimental - drug therapy | Dipeptidyl Peptidase 4 - metabolism | Gene Expression - drug effects | Kidney - pathology | Gene Expression - genetics | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Transforming Growth Factor beta1 - metabolism | Caspase 3 - metabolism | Body Weight - drug effects | Diabetic Nephropathies - drug therapy | Pyrrolidines - administration & dosage | Glucagon-Like Peptide 1 - blood | Male | Insulin - blood | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Pyrrolidines - pharmacology | Pyrrolidines - therapeutic use | Kidney - metabolism | Diabetic Nephropathies - physiopathology | Glomerular Basement Membrane - pathology | Adamantane - therapeutic use | Diabetes Mellitus, Experimental - complications | Adamantane - administration & dosage | Cyclic AMP - urine | Deoxyguanosine - analogs & derivatives | Kidney - physiopathology | Adamantane - analogs & derivatives | Diabetes Mellitus, Experimental - physiopathology | Receptors, Glucagon - genetics | Adamantane - pharmacology | Diabetic Nephropathies - pathology | Kidney - drug effects | Deoxyguanosine - urine | Diabetic Nephropathies - metabolism | Rats | Receptors, Glucagon - metabolism | Rats, Sprague-Dawley | Dipeptidyl-Peptidase IV Inhibitors - administration & dosage | Blood Glucose - drug effects | Eating - drug effects | Glomerular Basement Membrane - drug effects | Animals | Glucagon-Like Peptide-1 Receptor | Diabetes Mellitus, Experimental - pathology | Blood Glucose - metabolism | Index Medicus
Journal Article
Peptides, ISSN 0196-9781, 2011, Volume 32, Issue 4, pp. 835 - 838
Journal Article
Nature Chemical Biology, ISSN 1552-4450, 2014, Volume 10, Issue 8, pp. 656 - 663
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry, ISSN 0968-0896, 10/2012, Volume 20, Issue 19, pp. 5705 - 5719
Journal Article
Hypertension, ISSN 0194-911X, 09/2012, Volume 60, Issue 3, pp. 833 - 841
Journal Article
Journal of Agricultural and Food Chemistry, ISSN 0021-8561, 07/2014, Volume 62, Issue 26, pp. 6147 - 6158
Greek oregano (Origanum vulgare), marjoram (Origanum majorana), rosemary (Rosmarinus officinalis), and Mexican oregano (Lippia graveolens) are concentrated... 
DPP-IV | PTP1B | rosemary | marjoram | oregano | hispidulin | type 2 diabetes mellitus | PHENOLIC-COMPOUNDS | MEDICINAL HERBS | FOOD SCIENCE & TECHNOLOGY | IDENTIFICATION | ANTIOXIDANT PROPERTIES | LIPPIA | LAMIACEAE | TYROSINE-PHOSPHATASE 1B | MASS SPECTROMETRIC ANALYSIS | AGRICULTURE, MULTIDISCIPLINARY | ROSEMARY ROSMARINUS-OFFICINALIS | CHEMISTRY, APPLIED | EXTRACTS | Plant Extracts - chemistry | Crops, Agricultural - economics | Lippia - chemistry | Plant Extracts - pharmacology | Humans | Dipeptidyl-Peptidase IV Inhibitors - pharmacology | Protein Kinase Inhibitors - chemistry | Protein Kinase Inhibitors - analysis | Dipeptidyl-Peptidase IV Inhibitors - analysis | Crops, Agricultural - chemistry | Molecular Structure | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - genetics | Plant Leaves - chemistry | Recombinant Proteins - metabolism | Dipeptidyl-Peptidase IV Inhibitors - isolation & purification | Diabetes Mellitus, Type 2 - enzymology | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - antagonists & inhibitors | Recombinant Proteins - chemistry | Dipeptidyl-Peptidase IV Inhibitors - chemistry | Plant Extracts - isolation & purification | Recombinant Proteins - genetics | Protein Kinase Inhibitors - isolation & purification | Drug Discovery | Protein Tyrosine Phosphatase, Non-Receptor Type 1 - metabolism | Animals | Ligands | Molecular Docking Simulation | Origanum - chemistry | Protein Kinase Inhibitors - pharmacology | Diabetes Mellitus, Type 2 - drug therapy | Sus scrofa | Rosmarinus - chemistry | Index Medicus
Journal Article
Journal Article